Postprandial lipemia: Influence of aging;Lipemia pós-prandial. Influência do envelhecimento

Arquivos Brasileiros de Cardiologia

Volumn 85, Issue 1, 2005, Pages 15-19

  Issa, Jaqueline Scholz ^a   Diament, Jayme ^a   Forti, Neusa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aging; Lipid metabolism; Postprandial lipemia

Indexed keywords

ADULT; AGE; AGING; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; NORMAL HUMAN; POSTPRANDIAL STATE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 22644443189     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0066-782X2005001400004     Document Type: Article

References (25)

1. Thompson GR. Lipoprotein metabolism. In: A Handbook of Hyperlipidemia, Philadelphia: Current Science, 1990: 23-42.
2. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Ann Ver Biochem 1983; 52: 223.
3. Miller J. High density lipoproteins and atherosclerosis. Ann Ver Med 1980; 31: 97-108.
4. Zilversmit DB. Atherogenesis: A postprandial phenomenon. Circulation 1979; 60: 473-85.
5. Mamo JCL, Wheeler JR. Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein and albumin. Coran Artery Dis 1994; 5: 695-705.
6. Proctor SD, Mamo, JCL. Arterial fatty lesions have increased uptake of chylomicrons remnants but not low-density lipoproteins. Coron. Artery Dis 1996; 7: 239-45.
7. Brunzell J, Hazzard W, Porte D Jr etal. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest 1973; 52: 1578-85.
8. Bjorkegren J, Packard C, Hamsten A et al. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res 1996; 37: 76-86.
9. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage tih Hhal. J Lpid Res 1990; 31: 545-8.
10. Evans MA, Triggs EJ, Cheung M et al. Gastric emptying rate in elderly: implications for drug therapy. J Am Geriatr Soc 1981; 29: 201-05.
11. Kupfer RM, Heppell M, Haggith JW et al. Gastric emptying and small-bowel transit rate in the elderly. J Am Geriatr Soc 1985; 33: 340-03.
12. Fikry M. Exocrine pancreatic functions in the aged. J Am Geriatr Soc 1968; 16: 463-7.
13. Arora S, Kassarjian Z, Krasinki SD et al. Effect of age on tests of intestinal and hepatic function in healthy humans. Gastroenterology 1989; 96: 1560-5.
14. Krasinski SD, Conn JS, Schaefer EJ et al. Postprandial plasma retinyl ester response is greater in older subjects compared with younger subjects. J Clin Invest 1990; 85: 883-92.
15. Huttunen JK, Ehnholm C, Kikki M et al. Post-heparin plasma lipoprotein lipase in normal subjects and in patients with hypertriglyceridemia: correlation to sex, age and various parameters of triglyceride metabolism. Clin Sci Mol Med 1976; 50: 249-60.
16. Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein. E J Clin Invest 1987; 80: 1571-7.
17. Nestel P. Relationship between plasma triglycerides and removal of chylomicrons. J Clin Invest 1964; 43: 943-9.
18. Miller JS, Packard CJ. Heterogeneity of apolipoprotein B-100 containing lipoproteins: what we have learnt from kinetic studies. Curr Opin Lipidol 1998; 9: 197-202.
19. Reaven GM. Roleof insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
20. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest 2000; 106: 453-8.
21. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106; 473-81.
22. Cohen JC, Noakes TD, Benade AJS. Postprandial lipemia and chylomicron clearance in athletes and sedentary men. Am J Clin Nutr 1989; 49: 443-7.
23. Ericsson M, Johnson O, Tollin C et al. Serum lipoproteins, apolipoproteinsand intravenous fat tolerance in young athletes. Scand J Rehabil Med 1982; 14: 209-12.
24. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult treatment Panel III) JAMA 2001; 285: 2486-97.
25. Diretrizes Brasileiras sobre Dislipidemias, III. Arq Bras Cardiol 2001; 77(Supl. III): 1-48.